Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophils
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 27, 2010
Grant Date -
Sep 16, 2004
app pub date -
Feb 6, 2001
filing date -
Feb 11, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
N-(2-aryl-propionyl)-amides of formula (I) are described.The process for their preparation and pharmaceutical preparations thereof are also described.The amides of the invention are useful in the prevention and treatment of tissue damage due to the exacerbate recruitment of polymorphonuclear neutrophils (leukocytes PMN) at the inflammatory sites. In particular, the invention relates to the R enantiomers of N-(2-aryl-propionyl)amides of formula (I) for use in the inhibition of the chemotaxis of neutrophils induced by IL-8. The compounds of the invention are used in the treatment of psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, and rheumatoid arthritis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully